BCR-ABL1 Transcript Levels at 3 and 6 Months Are Better for Identifying Chronic Myeloid Leukemia Patients with Poor Outcome in Response to Second-Line Second-Generation Tyrosine Kinase Inhibitors after Imatinib Failure: A Report from a Single Institution

By  

Acta Haematologica, Vol. 134, Iss. 4, 2015-0 ,pp. : 248-254

Karger

Access to resources Recommend Favorite

Hyperdiploidy Associated with a High BCR-ABL Transcript Level May Identify Patients at Risk of Progression in Chronic Myeloid Leukemia

By  

Acta Haematologica, Vol. 127, Iss. 1, 2011-10 ,pp. : 7-9

Karger

Access to resources Recommend Favorite

Imatinib Mesylate Resistance in a Chronic Myeloid Leukemia Patient with a Novel e8a2 BCR-ABL Transcript Variant

By  

Acta Haematologica, Vol. 120, Iss. 3, 2008-11 ,pp. : 146-149

Karger

Access to resources Recommend Favorite

Occurrence of BCR-ABL1-Positive Chronic Myeloid Leukemia following Essential Thrombocythemia

By  

Acta Haematologica, Vol. 126, Iss. 4, 2011-09 ,pp. : 220-223

Karger

Access to resources Recommend Favorite

BCR-ABL1 transcript levels increase in peripheral blood but not in granulocytes after physical exercise in patients with chronic myeloid leukemia

By Jönsson Sofia   Olsson Bob   Jacobsson Stefan   Palmqvist Lars   Ricksten Anne   Ekeland-Sjöberg Kerstin   Wadenvik Hans  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 71, Iss. 1, 2011-02 ,pp. : 7-11

Informa Healthcare

Access to resources Recommend Favorite